NCT01950039View on ClinicalTrials.gov

Metabolic Effects of Betaine Supplementation

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

August 31, 2018

Conditions
ObesityDysglycemia
Interventions
DRUG

Betaine

Betaine or placebo administered orally in divided doses over 12 weeks

DRUG

Placebo

Placebo administered orally in divided doses over 3 months

Trial Locations (1)

02215

Joslin Diabetes Center and Brigham and Womens Hospital, Boston

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

Joslin Diabetes Center

OTHER

NCT01950039 - Metabolic Effects of Betaine Supplementation | Biotech Hunter | Biotech Hunter